Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) FCF Margin (2020 - 2025)

Historic FCF Margin for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q3 2025 value amounting to 29.69%.

  • Mirum Pharmaceuticals' FCF Margin rose 254800.0% to 29.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.39%, marking a year-over-year increase of 101100.0%. This contributed to the annual value of 2.77% for FY2024, which is 408900.0% up from last year.
  • Mirum Pharmaceuticals' FCF Margin amounted to 29.69% in Q3 2025, which was up 254800.0% from 9.32% recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' FCF Margin peaked at 29.69% during Q3 2025, and registered a low of 1056.41% during Q4 2021.
  • Its 5-year average for FCF Margin is 161.52%, with a median of 42.29% in 2023.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 9327300bps in 2022, then tumbled by -237500bps in 2025.
  • Mirum Pharmaceuticals' FCF Margin (Quarter) stood at 1056.41% in 2021, then soared by 88bps to 123.67% in 2022, then skyrocketed by 81bps to 23.89% in 2023, then surged by 79bps to 5.12% in 2024, then soared by 680bps to 29.69% in 2025.
  • Its FCF Margin stands at 29.69% for Q3 2025, versus 9.32% for Q2 2025 and 1.79% for Q1 2025.